Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of nebulized tobramycin in treatment of ventilator associated pneumonia
IRCT20150824023743N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tobramycin in ventilator-associated pneumonia (VAP), sponsored by Isfahan University of Medical Sciences. Started Apr 2017; status: completed.
02
Drugs
tobramycin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20150824023743N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150824023743N3.